mRNA |
DMOG |
GDSC1000 |
pan-cancer |
AAC |
0.026 |
0.4 |
mRNA |
chlorambucil |
CTRPv2 |
pan-cancer |
AAC |
0.024 |
0.4 |
mRNA |
sitagliptin |
CTRPv2 |
pan-cancer |
AAC |
-0.057 |
0.4 |
mRNA |
UNC0638:navitoclax (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.028 |
0.4 |
mRNA |
selumetinib:GDC-0941 (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.028 |
0.4 |
mRNA |
YM-155 |
GDSC1000 |
pan-cancer |
AAC |
0.026 |
0.4 |
mRNA |
GDC-0449 |
GDSC1000 |
pan-cancer |
AAC |
-0.028 |
0.4 |
mRNA |
CIL56 |
CTRPv2 |
pan-cancer |
AAC |
0.035 |
0.4 |
mRNA |
BRD-K75293299 |
CTRPv2 |
pan-cancer |
AAC |
-0.055 |
0.4 |
mRNA |
tigecycline |
CTRPv2 |
pan-cancer |
AAC |
-0.037 |
0.4 |